Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.46 |
| ▸ | PIK3R1 | P27986 | 4/20 | 0.46 |
| ▸ | MTOR | P42345 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12457554 | 0.80 | GPR119 (0.44) | POLBKDM4EALDH1A1USP2CNR2 | |
| SCHEMBL436107 | 0.80 | POLB (0.47) | POLBKMT2AALDH1A1CNR2MAPK1 | |
| SCHEMBL23467846 | 0.79 | POLB (0.58) | POLBKDM4EKMT2AALDH1A1CYP1A2 | |
| SCHEMBL3618906 | 0.79 | POLB (0.58) | POLBKDM4EAOC3KMT2AALDH1A1 | |
| SCHEMBL2794053 | 0.79 | POLB (0.58) | POLBKDM4EAOC3KMT2AALDH1A1 | |
| SCHEMBL1873066 | 0.79 | POLB (0.58) | POLBKDM4EAOC3KMT2AALDH1A1 | |
| SCHEMBL3466084 | 0.79 | POLB (0.58) | POLBKDM4EAOC3KMT2AALDH1A1 | |
| SCHEMBL30775408 | 0.79 | KDM4E (0.61) | POLBKDM4EAOC3KMT2AALDH1A1 | |
| SCHEMBL22627043 | 0.79 | POLB (0.58) | POLBKDM4EAOC3KMT2AALDH1A1 | |
| SCHEMBL10413396 | 0.79 | POLB (0.62) | POLBKDM4EAOC3KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577412-B2 | Corrosion inhibiting coating compositions | PRC-DESOTO INTERNATIONAL, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-20240174867-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2024-05-30 | — | — | US | claimed |
| EP-4301817-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-Desoto International, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| CN-117321150-A | Corrosion inhibiting coating composition | PRC-迪索托国际公司 | 2023-12-29 | — | — | CN | claimed |
| WO-2022187845-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2022-09-09 | — | — | WO | claimed |
| CN-113880859-A | 2-aryl-4-arylmethylamino pyrimidine compound and application thereof | 江西科技师范大学 | 2022-01-04 | — | — | CN | claimed |
| US-12577412-B2 | Corrosion inhibiting coating compositions | PRC-DESOTO INTERNATIONAL, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| WO-2025151695-A1 | COATING COMPOSITIONS COMPRISING MAGNESIUM OXIDE AND A LITHIUM COMPOUND | PRC-DESOTO INTERNATIONAL, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| US-12030857-B2 | Glucose uptake inhibitors | KADMON CORPORATION, LLC (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030857-B2 | Glucose uptake inhibitors | KADMON CORPORATION, LLC (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240174867-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4301817-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-Desoto International, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| CN-117321150-A | Corrosion inhibiting coating composition | PRC-迪索托国际公司 | 2023-12-29 | — | — | CN | disclosed |
| WO-2008143730-A2 | MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | RIB-X PHARMACEUTICALS, INC. (US) | 2008-11-27 | — | — | WO | disclosed |
| WO-2008106226-A2 | MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | RIB-X PHARMACEUTICALS, INC. (US) | 2008-09-04 | — | — | WO | disclosed |
| WO-2008106225-A1 | MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | RIB-X PHARMACEUTICALS, INC. (US) | 2008-09-04 | — | — | WO | disclosed |
| WO-2008106204-A1 | MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | RIB-X-PHARMACEUTICALS, INC. (US) | 2008-09-04 | — | — | WO | disclosed |
| WO-2008106224-A1 | MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | RIB-X PHARMACEUTICALS, INC. (US) | 2008-09-04 | — | — | WO | disclosed |
| US-20070191447-A1 | Novel heterocyclic compound | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070191447-A1 | Novel heterocyclic compound | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030857-B2 | Glucose uptake inhibitors | SLC2A1, SLC2A4, SLC2A2 | POLB 4532/4885KDM4E 2325/4885AOC3 4358/4885 |
| US-20070191447-A1 | Novel heterocyclic compound | OPRD1, GRIN3A, GRM3 | POLB 4028/4885KDM4E 2970/4885AOC3 1278/4885 |
| US-12577412-B2 | Corrosion inhibiting coating compositions | MGMT, MBD2, MECP2 | POLB 3399/4885KDM4E 41/4885AOC3 624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.